rAAV-PHP.B escapes the mouse eye and causes lethality whereas rAAV9 can transduce aniridic corneal limbal stem cells without lethality

Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, et al. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173–4.

Article  CAS  PubMed  Google Scholar 

Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an AAV vector expressing human SMN. Hum Gene Ther. 2018;29:285–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hordeaux J, Wang Q, Katz N, Buza EL, Bell P, Wilson JM. The neurotropic properties of AAV-PHP.B are limited to C57BL/6J mice. Mol Ther. 2018;26:664–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hordeaux J, Buza EL, Dyer C, Goode T, Mitchell TW, Richman L, et al. Adeno-associated virus-induced dorsal root ganglion pathology. Hum Gene Ther. 2020;31:808–18.

Article  CAS  PubMed  Google Scholar 

Agarwal S. High-dose AAV gene therapy deaths. Nat Biotechnol. 2020;38:910.

Article  Google Scholar 

Kishimoto TK, Samulski RJ. Addressing high dose AAV toxicity—“one and done” or “slower and lower”? Expert Opin Biol Ther. 2022;22:1067–71.

Article  PubMed  Google Scholar 

Hingorani M, Hanson I, van Heyningen V. Aniridia. Eur J Hum Genet. 2012;20:1011–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shortt AJ, Bunce C, Levis HJ, Blows P, Dore CJ, Vernon A, et al. Three-year outcomes of cultured limbal epithelial allografts in Aniridia and Stevens-Johnson Syndrome evaluated using the clinical outcome assessment in surgical trials assessment tool. Stem Cells Transl Med. 2014;3:265–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramaesh K, Ramaesh T, Dutton GN, Dhillon B. Evolving concepts on the pathogenic mechanisms of aniridia related keratopathy. Int J Biochem Cell Biol. 2005;37:547–57.

Article  CAS  PubMed  Google Scholar 

Mort RL, Bentley AJ, Martin FL, Collinson JM, Douvaras P, Hill RE, et al. Effects of aberrant Pax6 gene dosage on mouse corneal pathophysiology and corneal epithelial homeostasis. PLoS One. 2011;6:e28895.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li G, Xu F, Zhu J, Krawczyk M, Zhang Y, Yuan J, et al. Transcription factor PAX6 (Paired Box 6) controls limbal stem cell lineage in development and disease. J Biol Chem. 2015;290:20448–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramaesh T, Ramaesh K, Martin Collinson J, Chanas SA, Dhillon B, West JD. Developmental and cellular factors underlying corneal epithelial dysgenesis in the Pax6+/- mouse model of aniridia. Exp Eye Res. 2005;81:224–35.

Article  CAS  PubMed  Google Scholar 

Hickmott JW, Gunawardane U, Jensen K, Korecki AJ, Simpson EMA. Epistasis between PAX6Sey and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials. Gene Ther. 2018;25:524–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davis J, Duncan MK, Robison WG Jr, Piatigorsky J. Requirement for Pax6 in corneal morphogenesis: a role in adhesion. J Cell Sci. 2003;116:2157–67.

Article  CAS  PubMed  Google Scholar 

Ramaesh T, Collinson JM, Ramaesh K, Kaufman MH, West JD, Dhillon B. Corneal abnormalities in Pax6+/- small eye mice mimic human aniridia-related keratopathy. Investig Ophthalmol Vis Sci. 2003;44:1871–8.

Article  Google Scholar 

Mort RL, Douvaras P, Morley SD, Dora N, Hill RE, Collinson JM, et al. Stem cells and corneal epithelial maintenance: insights from the mouse and other animal models. Results Probl Cell Differ. 2012;55:357–94.

Article  PubMed  PubMed Central  Google Scholar 

Colon-Thillet R, Jerome KR, Stone D. Optimization of AAV vectors to target persistent viral reservoirs. Virol J. 2021;18:85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabatino DE, Bushman FD, Chandler RJ, Crystal RG, Davidson BL, Dolmetsch R, et al. Evaluating the state of the science for adeno-associated virus integration: an integrated perspective. Mol Ther. 2022;30:2646–63.

Article  CAS  PubMed  Google Scholar 

Becker J, Fakhiri J, Grimm D. Fantastic AAV gene therapy vectors and how to find them-random diversification, rational design and machine learning. Pathogens. 2022;11:756.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 2009;27:59–65.

Article  CAS  PubMed  Google Scholar 

Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, et al. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther. 2012;23:382–9.

Article  CAS  PubMed  Google Scholar 

Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol. 2016;34:204–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci. 2017;20:1172–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Q, Chan KY, Tobey IG, Chan YA, Poterba T, Boutros CL, et al. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS One. 2019;14:e0225206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hordeaux J, Yuan Y, Clark PM, Wang Q, Martino RA, Sims JJ, et al. The GPI-linked protein LY6A drives AAV-PHP.B transport across the blood-brain barrier. Mol Ther. 2019;27:912–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsuzaki Y, Tanaka M, Hakoda S, Masuda T, Miyata R, Konno A, et al. Neurotropic properties of AAV-PHP.B are shared among diverse inbred strains of mice. Mol Ther. 2019;27:700–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsuzaki Y, Konno A, Mochizuki R, Shinohara Y, Nitta K, Okada Y, et al. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain. Neurosci Lett. 2018;665:182–8.

Article  CAS  PubMed  Google Scholar 

Liguore WA, Domire JS, Button D, Wang Y, Dufour BD, Srinivasan S, et al. AAV-PHP.B administration results in a differential pattern of CNS biodistribution in non-human primates compared with mice. Mol Ther. 2019;27:2018–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gyorgy B, Meijer EJ, Ivanchenko MV, Tenneson K, Emond F, Hanlon KS, et al. Gene transfer with AAV9-PHP.B rescues hearing in a mouse model of usher syndrome 3A and transduces hair cells in a non-human primate. Mol Ther Methods Clin Dev. 2019;13:1–13.

Article  CAS  PubMed  Google Scholar 

Taiber S, Cohen R, Yizhar-Barnea O, Sprinzak D, Holt JR, Avraham KB. Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness. EMBO Mol Med. 2021;13:e13259.

Article  CAS  PubMed  Google Scholar 

Shubina-Oleinik O, Nist-Lund C, French C, Rockowitz S, Shearer AE, Holt JR. Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss. Sci Adv. 2021;7:eabi7629.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YA, Kankel MW, Hana S, Lau SK, Zavodszky MI, McKissick O, et al. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model. Gene Ther. 2022:1–12. https://doi.org/10.1038/s41434-022-00375-w.

Wu J, Solanes P, Nist-Lund C, Spataro S, Shubina-Oleinik O, Marcovich I, et al. Single and dual vector gene therapy with AAV9-PHP.B rescues hearing in Tmc1 mutant mice. Mol Ther. 2021;29:973–88.

Article  CAS  PubMed  Google Scholar 

Hana S, Peterson M, McLaughlin H, Marshall E, Fabian AJ, McKissick O, et al. Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice. Gene Ther. 2021;28:646–58.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif